Tag: Biotech and Pharma

Moderna said on Monday it has ​partnered with a global health coalition to develop a potential ‌vaccine against Bundibugyo ebolavirus, the strain linked to the ongoing Ebola outbreak in eastern Democratic Republic of Congo.

Η Lavipharm Α.Ε. ανακοινώνει την ολοκλήρωση της συναλλαγής για την απόκτηση των Αδειών Κυκλοφορίας, των εμπορικών σημάτων και των δικαιωμάτων εμπορικής εκμετάλλευσης και παραγωγής του DUROGESIC® από την Janssen Global Services LLC

Eli Lilly & Co. agreed to buy three vaccine developers for a total of up to about $3.8 billion, marking the drugmaker’s re-entry into the infectious disease space.

Biogen (BIIB.O), will advance its experimental Alzheimer’s drug to late-stage ​development after a mid-stage study showed it slowed mental decline and reduced ‌a key brain protein linked to the disease, although it failed to meet the trial’s main goal.

Telehealth company Hims & Hers’ stock plummeted in early trading Tuesday after posting a first-quarter loss and weak earnings guidance for the year ahead.

Novo Nordisk, opens new tab beat first-quarter profit forecasts and nudged up its full-year outlook on Wednesday, helped by stronger-than-expected sales of its new weight-loss pill ‌as it seeks to close the gap with U.S. rival Eli Lilly.

Pfizer shares climbed on Tuesday after the company delivered a first-quarter earnings beat and reaffirmed its full-year outlook.

Moderna defied expectations of a Covid-revenue slowdown on Friday as the drugmaker delivered strong first-quarter results fueled by a surge in international vaccine sales.

Bristol-Myers Squibb reported first-quarter earnings and revenue that topped analyst expectations, and reaffirmed its outlook for the full year.

Shares of Eli Lilly (LLY) rose sharply Thursday after the drugmaker delivered a beat-and-raise quarter driven partly by demand for its GLP-1 drugs.

GSK (GSK) reported higher earnings on increased specialty medicine sales and said it expects to pay a total dividend this year of 70 pence a share.

AstraZeneca (AZN)  beat first-quarter profit expectations and maintained its 2026 forecasts on Wednesday, supported by strong demand for its cancer and rare-disease drugs and investments in the key U.S. and China markets.

Novartis (NOVN) reported a drop in earnings as generic competition for its top-selling heart drug Entresto hit sales in the first months of the year.

Την Ετήσια Ενημέρωση Αναλυτών πραγματοποίησε σήμερα η Lavipharm A.E. σύμφωνα με το Οικονομικό Ημερολόγιο 2026 της Εταιρείας. Η παρουσίαση πραγματοποιήθηκε στο Χρηματιστήριο Αθηνών, στην Ένωση Θεσμικών Επενδυτών.

 Eli Lilly (LLY) said on Monday ‌it would buy privately held blood cancer treatment developer Ajax Therapeutics for up to $2.3 ​billion in cash.

Sanofi (SASY) beat first-quarter estimates on Thursday as demand for ‌its asthma and eczema drug Dupixent remained high, though analysts looked to incoming CEO Belén Garijo to ignite growth beyond the blockbuster drug.

Roche reported falling sales in the first three months of the year, as the strength of the Swiss franc and generic competition for some of its older drugs weighed on the drugmaker.

U.S. drugmaker Eli Lilly (LLY) is in advanced talks to acquire ​biotech firm Kelonia Therapeutics for more than $2 ‌billion, the Wall Street Journal reported on Sunday.

Abbott Laboratories reported first-quarter earnings in line with expectations and revenue above forecasts on Wednesday, but shares slipped after the medical device maker issued soft second-quarter profit guidance.

Novo Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.